product · release 2026-09-20

MBi Nutraceuticals Biodophilus Capsules

Structured fields rendered from the release dataset. Unknown values retain a reason; price is outside GIS.

Organisms, fibers and substances on this label

Lactobacillus acidophilus

Printed organisms · observed

Organism list

Quantities reflect printed organism rows.

Printed name and notes	Normalized organism	Printed code	Printed deposit	Printed quantity	Flags
Lactobacillus acidophilus	Lactobacillus acidophilus	not printed	not printed	1,600,000,000 CFU	T4; observed; quantity printed
Lactobacillus bifidus	Lactobacillus bifidus	not printed	not printed	1,600,000,000 CFU	T4; observed; quantity printed

Pack, dose and cost

What the label says beyond the organisms

Pack: 90 Capsule(s) · Capsule
Serving: 1 Capsule(s) · 3 serving(s) a day
Days of supply: 30
Potency per day: 9,600,000,000 CFU
Cost per day: no observed price in this release
Printed claims: 1 on the label (All Other). A printed claim is not evidence and does not enter any axis.
Other ingredients: 12 printed: Fructo-Oligosaccharides, Dextrose, Vitamin C, Vitamin E, Thiamine, Riboflavin, Niacinamide, PABA, Silica, Magnesium Stearate, Pyridoxine, Biotin
Label target groups: Adult (18 - 50 Years)
Suggested use: Recommendation: Take one capsule one to three times daily between meals or as directed by your health care professional.
UPC: 3 58301 22725 2

Printed potency

Quantity on the label

3,200,000,000 CFU per serving across 2 of 2 printed organism rows; potency basis The potency basis is not stated.

Evidence behind the label

Located human trials per organism

Organism on this label	PubMed records indexed as human randomized controlled trials
Lactobacillus acidophilus	381

Counts describe records matching each organism's published query, including trials of multi-ingredient products; they are not a count of trials of this product.

Context

Where this score sits

This formulation scores above 10.5% of the 4,101 scored formulations in this release. The score is a preference-dependent summary of the axes, not a health claim.

A140.00

A250.00

GIS45.50

Axes 1–2

Traceability and studiedness

Evidence queries are incomplete. A2 uses the known matching records as a lower bound.

Scored using the available matching evidence. Identity: Only the species or an unresolved identity is available. Quantity disclosure: 100.0%. Potency: The potency basis is not stated.

Axes 3–4

Measurement and brand panel

Not a measurement product, so this axis does not apply.

No brand review panel is published in this release.

Price column

Observed price

undefined: no permitted price observation in this release

Sensitivity

Preference-dependent summary

Preference interval 38.28–46.05; rank uncertainty 2889.00–3043.00; rank class 4.

Versions

Typed label snapshot edges

No typed edge in this release.

Preference tool

Weights slider

The readout recomputes the arithmetic summary from the published component JSON. Axis fields remain primary.

A1A2—

Elsewhere in this release

Findings computed over the whole corpus: Potency basis census · Strain dose match · Supplier code network

Tools: Unit value calculator · DSLD product check

Citation

Cite this page

Ivitskiy, I. (2026). MBi Nutraceuticals Biodophilus Capsules. Gut Registry, release 2026-09-20. Elanvale Ltd. https://gutregistry.com/p/biodophilus-capsules/

The underlying tables are published under CC BY 4.0: this page as CSV · as JSON · full release and data dictionary. Cell-level provenance names the source record and its observation date.

Citable atoms

Release claims

MBi Nutraceuticals Biodophilus Capsules: 0 of 2 observed organisms name a strain, and 0 print a deposit identifier. Latest observed label 231469. Window: NIH DSLD snapshot Sep 2026.
0 / 2 observed organisms · NIH DSLD snapshot Sep 2026 · product.organisms · checked 2026-09-20T00:00:00Z · snapshot b7633f732437
MBi Nutraceuticals Biodophilus Capsules: 0 of 1 observed label snapshots state a potency basis; latest basis is not stated. Quantities reflect printed organism rows. Window: NIH DSLD snapshot Sep 2026.
0 / 1 observed label snapshots · NIH DSLD snapshot Sep 2026 · product.potency · checked 2026-09-20T00:00:00Z · snapshot b7633f732437
MBi Nutraceuticals Biodophilus Capsules: 1 of 1 selected label snapshots have a numeric Gut Index Score; GIS 45.50 on the 100-point scale; rank class 4 of 4 across 3,279 scored formulations; nominal weights varied from 80.0% to 120.0% in preference sensitivity. Window: NIH DSLD snapshot Sep 2026.
1 / 1 selected label snapshots · NIH DSLD snapshot Sep 2026 · product.gis · checked 2026-09-20T00:00:00Z · snapshot b7633f732437
MBi Nutraceuticals Biodophilus Capsules has 1 observed versions across 1 formulation groups; last recorded edge type: no typed edge. Window: NIH DSLD snapshot Sep 2026.
1 / 1 formulation groups · NIH DSLD snapshot Sep 2026 · product.versions · checked 2026-09-20T00:00:00Z · snapshot b7633f732437
MBi Nutraceuticals Biodophilus Capsules: 0 of 1 observed versions have numeric prices; latest price No numeric price observation is available in this release.. Window: NIH DSLD snapshot Sep 2026.
0 / 1 observed label versions · NIH DSLD snapshot Sep 2026 · product.price · checked 2026-09-20T00:00:00Z · snapshot b7633f732437

Back to the release hub